Design, Synthesis, Biological Evaluation, and Molecular Modeling of Coumarin–P iperazine Derivatives as Acetylcholinesterase Inhibitors

RP Modh, SP Kumar, YT Jasrai… - Archiv der …, 2013 - Wiley Online Library
Acetylcholinesterase (AChE) is an important drug target for the treatment of Alzheimer's
disease. A novel series of coumarin–piperazine derivatives were synthesized and their …

Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease

KM Amin, DEA Rahman, HA Allam, HH El-Zoheiry - Bioorganic Chemistry, 2021 - Elsevier
Twenty novel 7-benzyloxycoumarin based compounds were synthesized with a variety of
bioactive chemical fragments. The synthesized compounds showed remarkable …

Synthesis of 2‐(2‐oxo‐2H‐chromen‐4‐yl)acetamides as potent acetylcholinesterase inhibitors and molecular insights into binding interactions

J Kara, P Suwanhom, C Wattanapiromsakul… - Archiv der …, 2019 - Wiley Online Library
Sixteen novel coumarin‐based compounds are reported as potent acetylcholinesterase
(AChE) inhibitors. The most active compound in this series, 5a (IC50 0.04±0.01 µM) …

Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors

SF Razavi, M Khoobi, H Nadri, A Sakhteman… - European journal of …, 2013 - Elsevier
A series of 4-hydroxycoumarin derivatives were designed and synthesized as new
acetylcholinesterase (AChE) inhibitors which could be considered for Alzheimer's disease …

Synthesis, biological evaluation and in silico study of 4-(benzo [d] thiazole-2-yl) phenols based on 4-hydroxy coumarin as acetylcholinesterase inhibitors

BBF Mirjalili, SA Fazeli Attar, F Shiri - Scientific Reports, 2024 - nature.com
Alzheimer's disease, characterized by cognitive decline and memory loss, is associated with
decreased acetylcholine levels due to acetylcholinesterase (AChE) activity. Compounds …

Coumarin derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies

S Singla, P Piplani - Bioorganic & Medicinal Chemistry, 2016 - Elsevier
A series of novel hybrids has been synthesized by linking coumarin moiety through an
appropriate spacer to various substituted heterocyclic amines and evaluated as dual binding …

Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's

JK Dhanjal, S Sharma, A Grover, A Das - Biomedicine & Pharmacotherapy, 2015 - Elsevier
Alzheimer's disease is a neurological disorder in which the patient suffers from memory loss
and impaired cognitive abilities. Though the main cause of the disease is not yet known …

Novel chalcone derivatives of ursolic acid as acetylcholinesterase inhibitors: Synthesis, characterization, biological activity, ADME prediction, molecular docking and …

H Şenol, M Ghaffari-Moghaddam, GÖA Toraman… - Journal of Molecular …, 2024 - Elsevier
Acetylcholinesterase (AChE) is a critical target in the prevention of Alzheimer's Disease (AD)
progression. With the goal of developing potential acetylcholinesterase inhibitors, a new …

Cholinesterase inhibition activity and docking simulation study of coumarin mannich base derivatives

A Kiani, L Jalili-baleh, Z Abdollahi, H Nadri… - Journal of Sciences …, 2019 - jsciences.ut.ac.ir
Inhibition of acetylcholinesterase and butyrylcholinesterase (AChE and BuChE) as two
major forms of cholinesterases (ChEs) is considered as the common approach for the …

Synthesis, biological evaluation, and molecular dynamics of novel coumarin based phosphorothioates as cholinesterase inhibitors

M El-Hussieny, MF ElMansy, EF Ewies… - Journal of Molecular …, 2023 - Elsevier
Inhibition of acetylcholinesterase has been validated as an effective target for treatment of
Alzheimer's disease by increasing the levels of acetylcholine and improving the …